Mistry, P. K., Lukina, E., Ben Turkia, H., Shankar, S. P., Baris, H., Ghosn, M., . . . Peterschmitt, M. J. (2017). Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial. Am J Hematol.
Chicago Style CitationMistry, Pramod K., et al. "Outcomes After 18 Months of Eliglustat Therapy in Treatment‐naïve Adults With Gaucher Disease Type 1: The Phase 3 ENGAGE Trial." Am J Hematol 2017.
MLA CitationMistry, Pramod K., et al. "Outcomes After 18 Months of Eliglustat Therapy in Treatment‐naïve Adults With Gaucher Disease Type 1: The Phase 3 ENGAGE Trial." Am J Hematol 2017.
Warning: These citations may not always be 100% accurate.